Aktuelle Ernährungsmedizin 2003; 28: 110-113
DOI: 10.1055/s-2003-36932
Kardiologie und Pneumologie
© Georg Thieme Verlag Stuttgart · New York

DGEM-Leitlinie Enterale Ernährung:
Kardiologie und Pneumologie

DGEM Guidelines Enteral Nutrition: Cardiology and PneumologyS.  D.  Anker1 , M.  John2 , H.  F.  Becker3 , M.  Böhm4 , F.  M.  Brunkhorst5 , C.  Vogelmeier6
  • 1Klinik für Kardiologie, Universitätsklinikum Charité, Berlin
  • 2Medizinische Klinik, Kardiologie, Angiologie, Pulmologie, Universitätsklinikum Charité, Berlin
  • 3Klinik für Innere Medizin - SP Pneumologie, Klinikum der Philipps-Universität Marburg
  • 4Klinik Innere Medizin III, Kardiologie, Univ.-Kliniken des Saarlandes, Homburg/Saar
  • 5Klinik für Anästhesiologie und Intensivmedizin, Universität Jena
  • 6Abteilung Pneumologie der Med. Poliklinik, Klinikum der Philipps-Universität Marburg
Further Information

Publication History

Publication Date:
27 January 2003 (online)

Literatur

  • 1 Cowie M R, Mosterd A, Wood D A. et al . The epidemiology of heart failure.  Eur Heart J. 1997;  18 208-225
  • 2 Berry C, Clark A L. Catabolism in chronic heart failure.  Eur Heart J. 2000;  21 521-532
  • 3 Mancini D M, Walter G, Reichek N. et al . Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.  Circulation. 1992;  85 1364-1373
  • 4 Anker S D, Coats A J. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.  Chest. 1999;  115 836-847
  • 5 Anker S D, Ponikowski P P, Clark A L. et al . Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.  Eur Heart J. 1999;  20 683-693
  • 6 Anker S D, Clark A L, Teixeira M M, Hellewell P G, Coats A J. Loss of bone mineral in patients with cachexia due to chronic heart failure.  Am J Cardiol. 1999;  83 612-615, A10
  • 7 Anker S D, Ponikowski P, Varney S. et al . Wasting as independent risk factor for mortality in chronic heart failure.  Lancet. 1997;  349 1050-1053
  • 8 Poehlman E T, Scheffers J, Gottlieb S S, Fisher M L, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure.  Ann Intern Med. 1994;  121 860-862
  • 9 Toth M J, Gottlieb S S, Goran M I, Fisher M L, Poehlman E T. Daily energy expenditure in free-living heart failure patients.  Am J Physiol. 1997;  272 E469-E475
  • 10 Anker S D, Chua T P, Ponikowski P. et al . Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.  Circulation. 1997;  96 526-534
  • 11 Anker S D, Clark A L, Kemp M. et al . Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting.  J Am Coll Cardiol. 1997;  30 997-1001
  • 12 Anker S D, Volterrani M, Pflaum C D. et al . Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.  J Am Coll Cardiol. 2001;  38 443-452
  • 13 Levine B, Kalman J, Mayer L, Fillit H M, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.  N Engl J Med. 1990;  323 236-241
  • 14 Rauchhaus M, Doehner W, Francis D P. et al . Plasma cytokine parameters and mortality in patients with chronic heart failure.  Circulation. 2000;  102 3060-3067
  • 15 King D, Smith M L, Lye M. Gastro-intestinal protein loss in elderly patients with cardiac cachexia.  Age Ageing. 1996;  25 221-223
  • 16 King D, Smith M L, Chapman T J, Stockdale H R, Lye M. Fat malabsorption in elderly patients with cardiac cachexia.  Age Ageing. 1996;  25 144-149
  • 17 Heymsfield S B, Casper K. Congestive heart failure: clinical management by use of continuous nasoenteric feeding.  Am J Clin Nutr. 1989;  50 539-544
  • 18 Freeman L M, Roubenoff R. The nutrition implications of cardiac cachexia.  Nutr Rev. 1994;  52 340-347
  • 19 Mustafa I, Leverve X. Metabolic and nutritional disorders in cardiac cachexia.  Nutrition. 2001;  17 756-760
  • 20 Otaki M. Surgical treatment of patients with cardiac cachexia. An analysis of factors affecting operative mortality.  Chest. 1994;  105 1347-1351
  • 21 Paccagnella A, Calo M A, Caenaro G. et al . Cardiac cachexia: preoperative and postoperative nutrition management.  JPEN J Parenter Enteral Nutr. 1994;  18 409-416
  • 22 Herndon D N, Hart D W, Wolf S E, Chinkes D L, Wolfe R R. Reversal of catabolism by beta-blockade after severe burns.  N Engl J Med. 2001;  345 1223-1239
  • 23 Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide.  Monaldi Arch Chest Dis. 2001;  56 261-264
  • 24 Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence.  Chest. 2000;  117 1S-4S
  • 25 Saudny-Unterberger H, Martin J G, Gray-Donald K. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1997;  156 794-799
  • 26 Koerts-de Lang E, Schols A M, Rooyackers O E, Gayan-Ramirez G, Decramer M, Wouters E F. Different effects of corticosteroid-induced muscle wasting compared with undernutrition on rat diaphragm energy metabolism.  Eur J Appl Physiol. 2000;  82 493-498
  • 27 Congleton J. The pulmonary cachexia syndrome: aspects of energy balance.  Proc Nutr Soc. 1999;  58 321-328
  • 28 Wilson D O, Rogers R M, Wright E C, Anthonisen N R. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial.  Am Rev Respir Dis. 1989;  139 1435-1438
  • 29 Schols A M, Wouters E F. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease.  Clin Chest Med. 2000;  21 753-762
  • 30 Thorsdottir I, Gunnarsdottir I, Eriksen B. Screening method evaluated by nutritional status measurements can be used to detect malnourishment in chronic obstructive pulmonary disease.  J Am Diet Assoc. 2001;  101 648-654
  • 31 Schols A M, Creutzberg E C, Buurman W A, Campfield L A, Saris W H, Wouters E F. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1999;  160 1220-1226
  • 32 Takabatake N, Nakamura H, Minamihaba O. et al . A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability.  Am J Respir Crit Care Med. 2001;  163 1314-1319
  • 33 Donahoe M, Rogers R M, Wilson D O, Pennock B E. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease.  Am Rev Respir Dis. 1989;  140 385-391
  • 34 Farber M O, Mannix E T. Tissue wasting in patients with chronic obstructive pulmonary disease.  Neurol Clin. 2000;  18 245-262
  • 35 Di Francia M, Barbier D, Mege J L, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1994;  150 1453-1455
  • 36 Schols A M. Nutrition in chronic obstructive pulmonary disease.  Curr Opin Pulm Med. 2000;  6 110-115
  • 37 Schols A M, Slangen J, Volovics L, Wouters E F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1998;  157 1791-1797
  • 38 Ferreira I M, Brooks D, Lacasse Y, Goldstein R S. Nutritional support for individuals with COPD: a meta-analysis.  Chest. 2000;  117 672-678

MD, PhD, Dr. med. Stefan D. Anker

Klinik für Kardiologie · Universitätsklinikum Charité

Augustenburger Platz 1

13353 Berlin

Email: s.anker@ic.ac.uk

    >